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GENE-BASED ANALYSIS OF A METAANALYSIS OF OSTEOARTHRITIS
GENOME WIDE ASSOCIATION STUDIES
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Purpose: There is ample evidence of the insufﬁciency of current
approaches to discover a large fraction of the genetic component of
complex diseases. Part of this missing component is already present in
the GWAS as multiple SNPs showing small differences between cases
and controls. The contribution of these multiple SNPs has been shown
in studies of OA among other diseases. However, we do not have vali-
dated tools to distinguish between genuine association and random
noise at these weak association levels. It is possible that using genes or
pathways as the analysis units could uncover part of this polygenic
component. However, reported Gene Based Analyses (GBA) have limi-
tations in important aspects like deﬁnition of gene boundaries,
consideration of linkage disequilibrium between SNPs and validation of
signiﬁcance thresholds. In addition, none of the previous studies has
been replicated in independent samples. Confronted with this situation,
we have tried to address the limitations of GBA to apply it to research in
OA genetics.
Methods: We have developed a procedure for GBA that incorporates
deﬁnition of genes according with the standardized recombination
rate (SRR) from the deCODE genetic map, a process for decorrelation
of the P values pertaining to each SNP in the gene that is based in
iterative and ordered Cholesky decomposition of the r2 matrix, an
evaluation of the goodness of ﬁt between the original P values and
the predicted from the decorrelated P values, estimation of a unique
summary statistic for each gene, and replication in additional
samples. This GBA has been applied to the meta-analysis of 9 OA
GWAS (partly reported). Six separate analyses were done for data
stratiﬁed by the 2 x 3 table of joint x gender with classes: knee and
hip for joint and women, men and combined for gender. All analyses
were done in a cluster of Unix nodes (SVG at the CESGA super-
computing centre).
Results: Application of the SRR-based deﬁnition of genes led to
inclusion of 5’ and 3’ sequences extensions of variable lengths with
median of 45.3 Kb (IQR ¼ 22.6-90.2 with sex averaged SRR). We also
deﬁned a set of “co-genes” as the fusion of genes overlapping by more
than 50 %. Decorrelation was obtained for 94.6 - 95.2 % of the 18022
genes with good accuracy as deﬁned by analysis based in Mahalanobis
distances. Results showed multiple associations four of them below
the genome-wide signiﬁcance threshold (5 x 10-8). Others were below
alternative thresholds that could be appropriate given the lower
number of independent tests in a GBA than in a GWAS. Therefore we
considered the 32 results shown in Table 1 worth pursuing for
replication.Table 1
Associations obtained with the GBA in function of thresholds and strata
Criteria Threshold Knee OA Hip OA
Women Men All Women Men All
GWAS < 5 x 10-8 1 1 2
# genes x #strata < 5 x 10-7 to 5 x 10-8 1 2 1 2
# genes < 3 x 10-6 to 5 x 10-7 3 1 2 2 1 4
# co-genes < 7 x 10-6 to 3 x 10-6 3 2 1 3
They included three associations highlighted in previous studies: GDF5with knee OA
in women (top association P¼1.9 x 10-9 obtained considering a co-gene), COL11A1
with hip OA in the combined analysis (top association also with a region including
overlapping genes, P¼2.2 x 10-6) and SUPT3H-RUNX2 with hip OA in men (P ¼ 3.5 x
10-7). These results do not amount to independent replication because of overlap
with previous studies. All the other associations selected for replication are novel.Conclusions: A new GBA approach has been developed that through
successful decorrelation of most SNPs in a GWAS OA metaanalysis has
allowed ﬁnding new associations. These results are very promisingbecause they include top associations below the GWAS threshold for
signiﬁcance and because it has retrieved three loci that were high-
lighted in previous OA studies. Therefore, this GBA strategy seems to
performwell as an extension of the GWAS. Validation of 32 associations
by replication with data from an independent large GWAS (arcOGEN
phase II) is under way.
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META-ANALYSIS IDENTIFIES NOVEL GENES INFLUENCING LEVELS OF
THE POTENTIAL OA BIOMARKERS SCOMP AND UCTX2
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Purpose: Reliable biochemical markers to sensitively monitor early
OA onset and/or progression would greatly favor early prognosis and
the search for effective therapies. Previous studies showed that
urinary C-telopeptide of type II collagen (uCTX2) is a sensitive marker
of whole body joint damage as reﬂected by its correlation to radio-
graphic signs of OA at different joint sites, however, it lacks speci-
ﬁcity. Serum cartilage oligomeric protein (sCOMP) associates with
both OA and age and has a high heritable component. Insight into the
innate variation of these markers within subjects may increase its
possible application as OA biomarker. Here, we set out to identify
novel genes inﬂuencing levels of the potential OA biomarkers sCOMP
and uCTX2.
Methods: Marker levels were measured in respectively 6 studies for
uCTX2 (N¼3316; studies from the Netherlands: GARP, Leiden Longevity
(LLS), Rotterdam Study II (RS-II) and the United Kingdom: TwinsUK,
CHINGFORD, VIDEO) and 7 studies for sCOMP (N¼4554; including the
same studies as for uCTX2 in addition to RS-I). For the discovery, we
applied a meta-analysis of genome wide association (GWA) studies for
these quantitative traits based on the summary statistics and P-values
using the Meta-Analysis Tool (METAL). Summary odds ratio's (ORs)
were estimated for compelling genes using the random-effects model of
DerSimonian and Laird, as implemented in the R package Meta (http://
www.r-project.org/). Heterogeneneity was examined using the I2.
Replication of SNPs with suggestive evidence for association (P < 10-5)
was performed by de novo genotyping in the Cohort Hip and Cohort
Knee (CHECK; N¼964).
Results: In the uCTX2 meta-GWA, we detected a total of 3 loci with
genome wide suggestive evidence for association. The most signiﬁcant
associationwas observed for a SNP located at chromosome 8 at 43.9 MB
within the CUB and sushi domain-containing protein 1 (CSMD1; OR ¼
1.14, P¼ 1.2*10-6). In the sCOMPmeta-GWA analysis, we found in total 6
loci with genome wide suggestive evidence for association. Among
them was a SNP within the mannose receptor C type 1 (MRC1) gene
with genome wide signiﬁcance (OR ¼ 0.78, P ¼ 2.5*10-10). Of note was
the association for a SNP within the sCOMP gene itself (OR ¼ 1.13, P ¼
2.0*10-5). Replication of these loci within CHECK resulted in additional
conﬁrmation with a similar effect and with signiﬁcant statistical
evidence for the uCTX2 gene CSMD1 (P ¼ 0.032) and a suggestive
evidence for the sCOMP gene MRC1 (P ¼ 0.066).
Conclusions: By applying GWAS meta-analysis, we are the ﬁrst to
identify a locus inﬂuencing innate levels of sCOMP with genome wide
signiﬁcance. This, and other loci associated with uCTX2 and sCOMP
levels will be studied and compared to uCTX2 and sCOMP itself for their
potential as biomarkers to detect OA at an early stage. In addition,
follow-up research will be aimed at studying their sensitivity and
speciﬁcity in association with OA phenotypes and the expression of
these genes in relevant tissues.
